Future research focused on exploring the impact of NOD2 polymorphisms in more detail, particularly in relation to trained immunity and vaccine responses, would be valuable in further understanding the genetic underpinnings of immune responses to BCG and its potential role in mitigating respiratory infections like RSV and SARS-CoV-2. This evidence concerns the gene NOD2 and respiratory tract infectious disorder.